FIELD: medicine.
SUBSTANCE: invention refers to clinical laser medicine and can be used in transmyocardial laser revascularisation (TMLR) both independently, and in combination with coronary artery bypass grafting (CABG). An transmyocardial laser revascularisation (TMLR) apparatus compsises a laser emitter, a optic-fibre system and a terminal for combined laser perforation and medicamentous injections where the laser emitter represents a solid-state Nd:YAG laser emitting at wavelength 1.4 mcm.
EFFECT: application of the invention allows improving quality and efficiency of TMLR and TMLR combined with CABG, reducing risk of operative and postoperative cardiac complications.
4 cl, 4 dwg, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DEVICE FOR REALISATION OF TRANSMYOCARDIAL LASER REVASCULARISATION | 2010 |
|
RU2420246C1 |
| DEVICE FOR REALISATION OF TRANSMYOCARDIAL LASER REVASCULARISATION | 2013 |
|
RU2553329C2 |
| METHOD FOR MYOCARDIAL REVASCULARIZATION IN CASE OF CORONARY ARTERY DISEASE | 2016 |
|
RU2614196C1 |
| METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2002 |
|
RU2292855C2 |
| METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE IN AN EXPERIMENT | 2003 |
|
RU2255699C2 |
| METHOD FOR LASER MYOCARDIUM REVASCULARIZATION | 2000 |
|
RU2195345C2 |
| METHOD FOR APPLYING LASER-MEDIATED REVASCULARIZATION OF MYOCARDIUM | 2000 |
|
RU2191045C2 |
| DEVICE FOR CARRYING OUT LASER-ASSISTED MYOCARDIUM REVASCULARIZATION | 2000 |
|
RU2207081C2 |
| METHOD OF ENDOVASCULAR TRANSMYOCARDIAL REVASCULARISATION | 2007 |
|
RU2359622C1 |
| SURGICAL METHOD FOR TREATING CARDIAC ISCHEMIA DISEASE | 1998 |
|
RU2200042C2 |
